News About: Pharm. Industry
Beckman Coulter teams up with Dong-A Pharm
Beckman Coulter Inc., one of the world's biggest diagnostic reagents and equipment companies, has joined with local leading drug maker Dong-A Pharmaceutical Co. that will exclusively supply Beckman Coulter's instrumen...
Ketotop honors at Korea's anti-arthritic brands survey
Pacific Pharm said recently that its Ketotop (ketoconzole) patch was consecutively chosen by local customers as No. 1 brands among anti-arthritic drugs in 2004 following the selection in 2003, the Korea Management Ass...
Consumer group named Aronamin Gold as the best brand
C&F Management held "2004 First Brand" event in a joint sponsorship with Korea Economy News Paper and Korea Consumer Forum wherein Aronamin Gold of Il Dong was nominated as the 2004 first brand in the multivitamin sec...
Testosterone replacement gel launched in Korea
Hanmi Pharm said on March 18 that it has launched the first-ever testosterone replacement gel, TestoGel, in Korea, for the treatment of low testosterone, also known as hypogonadism.
Developed by Laboratoires Besins...
Toughened drug advertisement guidelines hurt OTC sales
Tougher drug-related public advertisement guidelines, which is now regulated by provisions of drug advertisement layouts in the Korean Pharmaceutical Affairs Law, has affected overall OTC sales, market sources said re...
Eugene Science to sign MOU with Korea Ginseng Corp.President Roh Seung-kwon of Eugene Science (www.eugene21.com) contract an MOU for Euchol trademark use treaty with Korea Ginseng Corp. at Grand Intercontinental hotel for the ma...
|
Choong-wae wins in finasteride patent dispute
Choong-wae Pharm won in an injunction trial sought by MSD Korea, which stops Choong-wae from manufacturing Finastartablet (finasteride) for the treatment of benign prostate hyperplasia (BPH), which was launched in the...
MSD Korea opposesfinasteride lawsuit
Merck & Co's Korean subsidiary, MSD Korea, says it opposed the recent ruling of Seoul District Court to reject the injunction case of finasteride brought against Choong-wae Pharm, and appealed the case to Seoul High C...
Three pharmaceutical firms to benefit from strategic alliances with Pfizer Korea
Pharmaceutical business sources said that Pfizer Korea has established strategic alliances with three domestic pharmaceutical makers Dongshin Pharm, Ildong Pharm, and Jeil Pharm for marketing of Pfizer Korea's 15 dr...
Woori group to acquire majority Sudo equity.
Sudo pharmaceutical company announced on March 15 that the company issued 4 million stocks (5,600 won per a stock) to raise 22.4 billion won of new capitals by way of allocating all to the third party.
The third p...
